EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer

scientific article published on 21 March 2016

EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/09553002.2016.1145360
P8608Fatcat IDrelease_y726opav7ne4damdgznw7c73fu
P932PMC publication ID5116916
P698PubMed publication ID26999580

P50authorNadia FalzoneQ56986866
Katherine A VallisQ59667308
P2093author name stringLei Song
P2860cites workEfficient, pH-triggered drug delivery using a pH-responsive DNA-conjugated gold nanoparticle.Q52842256
111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.Q54059124
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheresQ57921075
Radioimmunotherapy with radioactive nanoparticles: biological doses and treatment efficiency for vascularized tumors with or without a central hypoxic areaQ84158568
99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistributionQ94469548
Renal clearance of quantum dotsQ24657265
Introduction to radiobiology of targeted radionuclide therapyQ26852029
Radiotherapy enhancement with gold nanoparticlesQ28288052
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewQ29617388
Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells.Q30571353
Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancerQ33414773
EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cellsQ34075391
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF NanomedicineQ34419681
Improving chemoradiotherapy with nanoparticle therapeuticsQ34564219
Gold nanoparticle imaging and radiotherapy of brain tumors in miceQ36853281
Molecular imaging and therapy of cancer with radiolabeled nanoparticlesQ37367335
Monolayer coated gold nanoparticles for delivery applicationsQ37934050
Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trendsQ37946340
Radiolabeled nanoparticles for multimodality tumor imagingQ38186026
Gold nanoparticle conjugates: recent advances toward clinical applicationsQ38190087
On the dose calculation at the cellular level and its implications for the RBE of (99m)Tc and ¹²³I.Q38990087
Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cellsQ39424008
The nanomedicine revolution: part 2: current and future clinical applications.Q39527453
ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.Q39557701
The role radius of curvature plays in thiolated oligonucleotide loading on gold nanoparticlesQ39885739
Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.Q40053032
Oligonucleotide-modified gold nanoparticles for intracellular gene regulation.Q40278223
Nuclear localization of EGF receptor and its potential new role as a transcription factorQ40782527
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.Q42011060
Thermal stability of DNA functionalized gold nanoparticlesQ42873705
Rigid, specific, and discrete gold nanoparticle/antibody conjugatesQ43664684
Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.Q44576368
Gold nanoparticles as carriers for efficient transmucosal insulin delivery.Q46868738
Colloidal gold: a novel nanoparticle vector for tumor directed drug deliveryQ47325811
Factors influencing the sensitivity of tumor imaging with a receptor-binding radiopharmaceutical.Q47972181
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue11
P921main subjectnanoparticleQ61231
P304page(s)716-723
P577publication date2016-03-21
P1433published inInternational Journal of Radiation BiologyQ2093427
P1476titleEGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer
P478volume92

Reverse relations

cites work (P2860)
Q55334502111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells.
Q89736557Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Coadministration of Targeting Ligand
Q92068202Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles
Q92255791Laser-driven radiation: Biomarkers for molecular imaging of high dose-rate effects
Q37678134Radiation dose enhancement in skin therapy with nanoparticle addition: A Monte Carlo study on kilovoltage photon and megavoltage electron beams
Q47316470Radiosensitization of ultrasmall GNP-PEG-cRGDfK in ALTS1C1 exposed to therapeutic protons and kilovoltage and megavoltage photons.
Q41514186Recent progress on nanoparticle-based drug delivery systems for cancer therapy.
Q58764832Subcellular Targeting of Theranostic Radionuclides
Q90478729Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody
Q90169641Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy

Search more.